Skip to main content

Table 1 Mechanism of m6A modification occurring in viruses

From: N6-methyladenosine modification—a key player in viral infection

Type

Virus

Protein

Biological function

Refs.

 

SARS-CoV-2

METTL3

Enhance m6A modification of SARS-CoV-2 RNA, viral load, and proviral gene expression

[52]

 

Interacts with the N region of RdRp

[54]

 

Inhibits RIG-I binding to SARS-CoV-2 RNA

[52]

 

RBM15

Regulates the expression of multiple target genes

[55]

RNA virus

Exacerbates the inflammatory response and promotes cell death signaling pathway in COVID-19

 

HIV-1

METTL3

Promotes Gag protein expression and the level of capsid p24 release

[75]

 

METTL14

 

YTHDF1-3

Binds with HIV-1 RNA to negatively regulate HIV-1 post-entry infection by blocking viral reverse transcription

 

KSHV

YTHDC1

Binds to m6A sites on the RTA pre-mRNA

[85]

 

FTO

Decrease m6A level and enhanced TPA induction of KSHV lytic gene expression

 

YTHDF2

Decrease the half-life of KSHV transcripts

[86]

 

EBV

METTL14

Cooperates with EBNA3C to promote cell growth and proliferation

[81]

DNA virus

Increases the tumorigenic activity of EBV-transformed cells

 

METTL3

BZLF1 represses METTL3 expression by binding to promoter

[82]

 

Promotes the production of progeny virions and expression of the late viral lytic protein BKRF4, BALF4

[28]

 

Promotes EBNA2 expression

[83]

 

YTHDF1

Promotes the binding of RNA degradation complexes (ZAP, DDX17, and DCP2) to the mRNAs of BZLF1 and BRLF1 to suppress EBV infection and replication

[84]

 

YTHDF2

Increases KLF4 mRNA instability

[82]

  1. SARS-CoV-2 severe acute respiratory syndrome coronavirus clade 2, RBM15 RNA-binding motif protein 15, RdRp RNA-dependent RNA polymerase